NYSE:HYH

Halyard Health (HYH) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$56.93
$57.91
50-Day Range
N/A
52-Week Range
$38.22
$61.52
Volume
886,271 shs
Average Volume
438,537 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
HYH stock logo

About Halyard Health Stock (NYSE:HYH)

Avanos Medical, Inc. operates as a medical technology company. It focuses on delivering clinically medical device solutions to improve patients' quality of life. The firm's portfolio of product offerings focuses on respiratory and digestive health, along with surgical and interventional pain management to improve patient outcomes and reduce the cost of care. Its brands include ON-Q, Coolife, Microcuff, MIC-Key, Quilbloc and Home pump. The company was founded on February 25, 2014 and is headquartered in Alpharetta, GA.

HYH Stock News Headlines

Halyard Health earnings preview: what Wall Street is expecting
HALYARD PRINCIPALS LLC's Net Worth
The 2024 crypto bull run has already started — don’t get left behind
One of the first ever crypto millionaires who bought Bitcoin when it was trading for just $5 in 2011 is back with his next huge prediction. A newly approved government regulation is set to flood trillions of dollars into the crypto markets, leading to the FINAL crypto bull run. One of the "Kings of Crypto" has revealed five tiny cryptos that could soar over the course of 2024. Potentially resulting in gains as big as 10X, 50X, or even 100X over the next 12 months.
Health Care
Avanos Medical Inc (AVNS)
The 2024 crypto bull run has already started — don’t get left behind
One of the first ever crypto millionaires who bought Bitcoin when it was trading for just $5 in 2011 is back with his next huge prediction. A newly approved government regulation is set to flood trillions of dollars into the crypto markets, leading to the FINAL crypto bull run. One of the "Kings of Crypto" has revealed five tiny cryptos that could soar over the course of 2024. Potentially resulting in gains as big as 10X, 50X, or even 100X over the next 12 months.
Halyard Health Announces New Drainage System, Stock Down
See More Headlines
Receive HYH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Halyard Health and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/01/2017
Today
5/06/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical Appliances & Supplies
Sub-Industry
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Optionable
Beta
N/A
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives

  • Joseph F. Woody
    Chief Executive Officer & Executive Director
  • Michael C. Greiner
    Chief Financial Officer & Senior Vice President
  • Lee Burnes
    Senior VP-Global Research & Development
  • Michelle Scharfenberg
    Senior VP, Chief Ethics & Compliance Officer
  • Rhonda D. Gibby
    Chief Human Resources Officer & Senior VP

HYH Stock Analysis - Frequently Asked Questions

How were Halyard Health's earnings last quarter?

Halyard Health, Inc. (NYSE:HYH) posted its earnings results on Wednesday, November, 1st. The medical instruments supplier reported $0.60 EPS for the quarter, topping analysts' consensus estimates of $0.47 by $0.13. The medical instruments supplier had revenue of $401.40 million for the quarter, compared to analysts' expectations of $394.54 million. The firm's revenue for the quarter was up 1.0% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.48 earnings per share.

What other stocks do shareholders of Halyard Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Halyard Health investors own include Kimberly-Clark (KMB), Allergan (AGN), Cisco Systems (CSCO), General Electric (GE), Kinder Morgan (KMI), Gilead Sciences (GILD), Intel (INTC), Ionis Pharmaceuticals (IONS) and Johnson & Johnson (JNJ).

This page (NYSE:HYH) was last updated on 5/7/2024 by MarketBeat.com Staff

From Our Partners